(Q38393636)

English

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial

scientific article published on 14 April 2016

Statements

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial (English)
14 April 2016

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit